|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 12, 385-391, Copyright © 1997 by European Association for Cardio-thoracic Surgery
P Girard, L Spaggiari, P Baldeyrou, T Le Chevalier, A Le Cesne, B Escudier, M Filaire and D Grunenwald
OBJECTIVE: To assess, using a large homogeneous retrospective series, the
prognostic value of the number of resected pulmonary metastases, and thus,
to determine to what extent the number of resectable metastases should
influence the surgical decision. METHODS: The survival analysis of all
patients operated on for pulmonary metastases at a single center, the
comparisons of 2 'histologic' groups (sarcoma and carcinoma) and, within
each histologic group, of three subgroups with different numbers of
resected metastases (1, 2-4, and > or = 5) were performed. The log-rank
test was used to compare survival curves. RESULTS: Among 575 adult patients
operated on with curative intent before December 1991, the first operation
allowed the complete resection of a known number of histologically proven
viable pulmonary metastases in 230 and 151 patients with metastases from
carcinoma and sarcoma, respectively. The 5- and 10-year probabilities of
survival (Kaplan-Meier) were 37 and 23%, respectively in carcinoma
patients, and 31 and 28%, respectively in sarcoma patients (log-rank test:
ns). Only the difference between patients with 1 versus 2-4 metastases from
carcinoma proved statistically significant (P = 0.02), with 5-year survival
estimates of 41 and 25%, respectively. Beside survival, the only
significant difference between the subgroups of patients with different
numbers of resected metastases was the mean interval between the diagnosis
of pulmonary metastases and the resection of pulmonary metastases, which
was significantly longer in patients with several metastases in both
histologic groups. CONCLUSIONS: In patients with resectable pulmonary
metastases from sarcoma or carcinoma, the number of metastases should have
little influence on the surgical decision, except for delaying this
decision in patients with several metastases until a significant interval,
with or without treatment, has shown that metastatic disease remains
resectable and confined to the lungs.
ARTICLES
Should the number of pulmonary metastases influence the surgical decision?
Thorax Department, Institut Mutualiste Montsouris, Paris, France. pgirard@imm.fr
This article has been cited by other articles:
![]() |
S. L. Spunt, S. X. Skapek, and C. M. Coffin Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcomas Oncologist, June 1, 2008; 13(6): 668 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Loehe, S. Kobinger, R. A. Hatz, T. Helmberger, U. Loehrs, and H. Fuerst Value of systematic mediastinal lymph node dissection during pulmonary metastasectomy Ann. Thorac. Surg., July 1, 2001; 72(1): 225 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Mineo, V. Ambrogi, M. Paci, N. Iavicoli, E. Pompeo, and I. Nofroni Transxiphoid Bilateral Palpation in Video-Assisted Thoracoscopic Lung Metastasectomy Arch Surg, July 1, 2001; 136(7): 783 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Antunes, J. Bernardo, M. Salete, D. Prieto, L. Eugenio, and P. Tavares Excision of pulmonary metastases of osteogenic sarcoma of the limbs Eur. J. Cardiothorac. Surg., May 1, 1999; 15(5): 592 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Spaggiari, D. H. Grunenwald, P. Girard, P. Solli, and T. Le Chevalier Pneumonectomy for lung metastases: indications, risks, and outcome Ann. Thorac. Surg., December 1, 1998; 66(6): 1930 - 1933. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |